Jaap Stuut

Jaap Stuut is an accomplished executive with extensive experience in leadership roles within the medical diagnostics and healthcare sectors. Currently serving as President and General Manager EMEAI at Sakura Finetek Europe since April 2024, Jaap has previously held the position of Chief Executive Officer at Immunodiagnostic Systems (IDS) from July 2013 to April 2024, where responsibilities included developing and executing business strategies for sustainable growth. Jaap's career also includes roles as Marketing Director and Head of Strategic Marketing at IDS, Director at SHO Centra voor medische diagnostiek, Global Marketing Director at Novartis, and Marketing & Business Development Director at Roche Diagnostics. Jaap's educational background encompasses an MBA in Strategy from NIMBAS, along with studies at Harvard Business School and London Business School.